The Effect of Switch Treatment on Liver Fibrosis and qHBsAg Levels in Patients with Chronic Hepatitis B

---

Atıf İçin Kopyala

Yesilyurt E., Kaya M., Dindar G., Acikgoz S. B., Guzelbulut F., Sezikli H., ...Daha Fazla

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.26, ss.69-73, 2020 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 26
• Basım Tarihi: 2020
• Doi Numarası: 10.4274/vhd.galenos.2020.2020.0008
• Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.69-73
• Kocaeli Üniversitesi Adresli: Evet

Özet

Objectives: The aim of this study was to evaluate the relationship between clinical, biochemical, serological parameters, fibroscan imaging in terms of fibrosis and quantitative hepatitis B surface antigen (qHBsAg) levels in patients with chronic hepatitis B (CHB) infection whose treatment has been switched from LAM to TDF.